RxDoctor Payments Data

Michael Leonardi

Pediatrics · Charleston, SCNPI 1932295425

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $875 of the $986 with a category attached, or 88.7%. GSK accounts for 88.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2020 at $889 and has fallen 94.0% since, to $53 in 2024.

$986in general payments, 2019–2025

Across 7 payments — averaging $140.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$875
  • Neuraxis, Inc.$53
  • Ironshore Pharmaceuticals Inc.$25
  • Sobi, Inc$18
  • Sanofi Pasteur Inc.$11
  • Pfizer$4
$2,038,962in research payments, 2019–2025

Across 502 payments — averaging $4061.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Modernatx, Inc.$1.2M
  • Merck$237K
  • Pfizer$197K
  • GSK$167K
  • AstraZeneca$107K
  • Sanofi Pasteur Inc.$84K
  • plus $39K from 2 others

What the payments were for

  • Consulting fees$87589%
  • Food & beverage$11111%

General payments by program year

19
20
21
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK1$875
Neuraxis, Inc.1$53
Ironshore Pharmaceuticals Inc.2$25
Sobi, Inc1$18
Sanofi Pasteur Inc.1$11
Pfizer1$4

How this compares

$986 in reported general payments places this provider in the 75th percentile of 969 pediatrics providers in South Carolina.

See all pediatrics providers in South Carolina →

Other pediatrics in Charleston

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →